Dogwood Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
2.340
+0.030 (1.30%)
Dec 20, 2024, 4:00 PM EST - Market closed
Dogwood Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 4.31 | 3.72 | 4.25 | 4.85 | 9.81 | 1.38 | |
| Research & Development | 1.51 | 1.73 | 8.07 | 10.8 | 0.19 | 0.8 | |
| Operating Expenses | 5.82 | 5.45 | 12.32 | 15.64 | 10.01 | 2.18 | |
| Operating Income | -5.82 | -5.45 | -12.32 | -15.64 | -10.01 | -2.18 | |
| Interest Expense | - | - | - | - | -0.38 | -0.3 | |
| Interest & Investment Income | 0.1 | 0.15 | 0.07 | 0.01 | - | - | |
| Other Non Operating Income (Expenses) | - | - | - | - | 0.04 | - | |
| EBT Excluding Unusual Items | -5.73 | -5.3 | -12.25 | -15.64 | -10.35 | -2.47 | |
| Legal Settlements | - | - | - | -0.33 | - | - | |
| Pretax Income | -5.73 | -5.3 | -12.25 | -15.96 | -10.35 | -2.47 | |
| Net Income | -5.73 | -5.3 | -12.25 | -15.96 | -10.35 | -2.47 | |
| Net Income to Common | -5.73 | -5.3 | -12.25 | -15.96 | -10.35 | -2.47 | |
| Shares Outstanding (Basic) | 1 | 1 | 0 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 1 | 1 | 0 | 0 | 0 | 0 | |
| Shares Change (YoY) | 20.17% | 69.62% | 32.91% | 69.06% | 1.95% | - | |
| EPS (Basic) | -6.42 | -7.05 | -27.66 | -47.90 | -52.50 | -12.80 | |
| EPS (Diluted) | -6.42 | -7.05 | -27.66 | -48.00 | -52.50 | -12.80 | |
| Free Cash Flow | -4.13 | -4.87 | -11.47 | -15.69 | -3.9 | -2.09 | |
| Free Cash Flow Per Share | -4.63 | -6.48 | -25.90 | -47.09 | -19.76 | -10.82 | |
| EBIT | -5.82 | -5.45 | -12.32 | -15.64 | -10.01 | -2.18 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.